CA2192813C - Procedes d'induction de l'expression de genes par rayonnement ionisant - Google Patents

Procedes d'induction de l'expression de genes par rayonnement ionisant Download PDF

Info

Publication number
CA2192813C
CA2192813C CA002192813A CA2192813A CA2192813C CA 2192813 C CA2192813 C CA 2192813C CA 002192813 A CA002192813 A CA 002192813A CA 2192813 A CA2192813 A CA 2192813A CA 2192813 C CA2192813 C CA 2192813C
Authority
CA
Canada
Prior art keywords
cells
jun
promoter
dna
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002192813A
Other languages
English (en)
Other versions
CA2192813A1 (fr
Inventor
Tsuneya Ohno
Ralph R. Weichselbaum
Donald W. Kufe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Chicago
Dana Farber Cancer Institute Inc
Original Assignee
University of Chicago
Dana Farber Cancer Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/241,863 external-priority patent/US5571797A/en
Application filed by University of Chicago, Dana Farber Cancer Institute Inc filed Critical University of Chicago
Publication of CA2192813A1 publication Critical patent/CA2192813A1/fr
Application granted granted Critical
Publication of CA2192813C publication Critical patent/CA2192813C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne un procédé destiné à administrer un rayonnement ionisant à des tissus spécifiques, ayant pour effet l'activation d'une molécule d'ADN comprenant un activateur-promoteur sensible au rayonnement, lié fonctionnellement à une région codante, laquelle code au moins un polypeptide. La source de rayonnement peut d'une manière générale prendre la forme d'un radionucléide capable d'émissions gamma ou béta. L'invention concerne également des procédés de régulation de l'expression de polypeptides et d'inhibition de la croissance de tumeurs à l'aide de ces molécules d'ADN.
CA002192813A 1994-05-11 1995-05-11 Procedes d'induction de l'expression de genes par rayonnement ionisant Expired - Fee Related CA2192813C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/241,863 1994-05-11
US08/241,863 US5571797A (en) 1994-05-11 1994-05-11 Method of inducing gene expression by ionizing radiation
PCT/US1995/005959 WO1995031559A2 (fr) 1994-05-11 1995-05-11 Procedes d'induction de l'expression de genes par rayonnement ionisant

Publications (2)

Publication Number Publication Date
CA2192813A1 CA2192813A1 (fr) 1995-11-23
CA2192813C true CA2192813C (fr) 2007-05-01

Family

ID=38051341

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002192813A Expired - Fee Related CA2192813C (fr) 1994-05-11 1995-05-11 Procedes d'induction de l'expression de genes par rayonnement ionisant

Country Status (1)

Country Link
CA (1) CA2192813C (fr)

Also Published As

Publication number Publication date
CA2192813A1 (fr) 1995-11-23

Similar Documents

Publication Publication Date Title
US5571797A (en) Method of inducing gene expression by ionizing radiation
US5770581A (en) Gene transcription and ionizing radiation: methods and compositions
US5817636A (en) Control of gene expression by ionizing radiation
Jäättelä et al. Major heat shock protein hsp70 protects tumor cells from tumor necrosis factor cytotoxicity.
Datta et al. Expression of the jun-B gene during induction of monocytic differentiation
CA2192813C (fr) Procedes d'induction de l'expression de genes par rayonnement ionisant
JP2003500422A (ja) 石灰化した腫瘍および組織を治療するためのオステオネクチンに基づく毒性遺伝子治療
WO2001030799A1 (fr) Renforcement et confinement de l'expression genique en therapie anticancereuse
EP1139750A1 (fr) Therapie genique toxique a base de sialoproteine osseuse permettant de traiter les tissus et les tumeurs calcifies
US20030213006A1 (en) Beta-hcg promoter based tumor restrictive gene expression for cancer theraphy
WO2001090344A1 (fr) $g(b)-hcg promoter based tumor-restrictive gene expression for cancer gene therapy
US20040038232A1 (en) Compositions and methods for modulating tumor specific expression
CA2410094A1 (fr) Compositions et methodes destinees a la modulation de l'expression specifique des tumeurs
WO2001032685A2 (fr) Expression des genes dirigee par un super-promoteur de psa

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed